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Paramyxovirus fusion proteins have two heptad repeat domains, HR1 and HR2, that have been implicated in the fusion
activity of the protein. Peptides from these two domains form a six-stranded, coiled-coil with the HR1 sequences forming a
central trimer and three molecules of the HR2 helix located within the grooves in the central trimer (Baker et al., 1999, Mol.
Cell 3, 309; Zhao et al. 2000, Proc. Natl. Acad. Sci. USA 97, 14172). Nonconservative mutations were made in the HR2 domain
of the Newcastle disease virus fusion protein in residues that are likely to form contacts with the HR1 core trimer. These
residues form the hydrophobic face of the helix and adjacent residues (“a” and “g” positions in the HR2 helical wheel
structure). Mutant proteins were characterized for effects on synthesis, steady-state levels, proteolytic cleavage, and surface
expression as well as fusion activity as measured by syncytia formation, content mixing, and lipid mixing. While all mutant
proteins were transport competent and proteolytically cleaved, these mutations did variously affect fusion activity of the
protein. Nonconservative mutations in the “g” position had no effect on fusion. In contrast, single changes in the middle “a”
position of HR2 inhibited lipid mixing, content mixing, and syncytia formation. A single mutation in the more carboxyl-terminal
“a” position had minimal effects on lipid mixing but did inhibit content mixing and syncytia formation. These results are
consistent with the idea that the HR2 domain is involved in posttranslational interactions with HR1 that mediate the close
approach of membranes. These results also suggest that the HR2 domain, particularly the carboxyl-terminal region, plays an
additional role in fusion, a role related to content mixing and syncytia formation. © 2001 Academic Press
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(INTRODUCTION
Entry of enveloped viruses requires the fusion of viral
membranes with cellular membranes, a process directed
by membrane-associated viral fusion proteins. Viral fu-
sion proteins have sequence elements important in fu-
sion including fusion peptide and heptad repeat (HR)
domains. Fusion peptides are domains proposed to in-
sert into target or cellular membranes disordering the
lipids in those membranes and attaching the protein to
target membranes (Hernandez et al., 1996). HR domains
have been implicated in pulling target and attack or
virion membranes into close proximity required for sub-
sequent membrane fusion (Weissenhorn et al., 1999).
The Paramyxoviridae fusion (F) proteins are synthe-
sized as precursors, F0, and proteolytic cleavage to the
isulfide linked F1 and F2 polypeptides is required for
usion activity of the protein. This cleavage places the F
rotein fusion peptide at the amino terminus of F1. Ad-
acent to the fusion peptide is a heptad repeat region
HR1), which mutational analysis has shown to be im-
ortant in the fusion activity of the protein (Sergel-Ger-
ano et al., 1994). Paramyxovirus F proteins also have a1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (508) 856-5920. E-mail: trudy.morrison@umassmed.edu.
343eptad repeat domain (HR2) adjacent to the transmem-
rane domain of the F1 protein. The HR2 domain has also
been implicated in the fusion activity by mutational anal-
ysis as well as analysis of peptides with sequences of
the HR2 domain (Buckland et al., 1992; Ghosh et al., 1998;
Lambert et al., 1996; Rapaport et al., 1995; Reitter et al.,
995; Wild and Buckland, 1997; Yao and Compans, 1996;
oung et al., 1997). HR2 peptides inhibit fusion and also
orm complexes with peptides from the HR1 domain
Joshi et al., 1998; Young et al., 1999) to form a six-
stranded structure with a central core trimer of HR1
peptides with three HR2 peptides bound to the trimer
surface (Baker et al., 1999; Zhao et al., 2000). These
results have been interpreted to indicate that HR2 pep-
tides mimic the HR2 domain in the intact protein, inter-
fering with interactions of the HR2 domain with HR1
resulting in fusion inhibition. One interpretation of this
inhibition is that the HR1 domain is not complexed with
the HR2 domain prior to activation of fusion and is ac-
cessible to HR2 peptide binding. The recently published
crystal structure of the Newcastle disease virus (NDV) F
protein does not clarify this issue since neither the HR2
domain nor the amino-terminal part of the HR1 domain
was visible in the structure (Chen et al., 2001).
These considerations suggest that the F protein is
synthesized in a prefusion conformation that changes
upon activation of fusion. Fusion activation requires
0042-6822/01 $35.00
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344 MCGINNES ET AL.cleavage of the molecule that is accompanied by a
conformational change (Hsu et al., 1981). Additional con-
formational changes with onset of fusion are likely,
changes that are analogous to those detected upon acid
activation of the influenza HA protein (Carr and Kim,
1993; Hernandez et al., 1996) or to changes detected in
the retroviral envelope proteins upon attachment to re-
ceptors (Chan and Kim, 1998; Furuta et al., 1998; Hernan-
dez et al., 1997; Tan et al., 1997; Wiessenhorn et al., 1997).
o understand structures of the prefusion and postfusion
onformations of the NDV F protein, we have extended
ur previous mutational analysis of the HR2 domain
Reitter et al., 1995) with a focus on nonconservative
hanges of residues that may be important to HR1 do-
ain interactions. All mutant proteins resulted in trans-
ort competent proteins, suggesting that normal com-
lex formation between HR1 and HR2 domains is not
ecessary for folding of the prefusion form of the protein.
hese mutations did, however, variously affect fusion
ctivity of the protein. We have found that single, non-
onservative mutations can significantly inhibit fusion.
urthermore, the position of the change within the hep-
FIG. 1. Description of mutants. (A) A diagram of the F protein sequenc
to the fusion activity of the protein. (B) The sequence of the HR2 dom
position residues in the NDV HR2 heptad repeat are indicated by num
of the mutants characterized. The mutants are identified by the positionad repeat is important for the degree of inhibition and
he step in the fusion process that is inhibited. Results
w
Kuggest that the HR2 domain may be involved in steps
ubsequent to the close approach of two membranes.
RESULTS
utagenesis of the HR2 domain
Figure 1A shows a diagram of the linear sequence of
he NDV F protein with the HR domains indicated. The
R2 domain is minimally defined here as the region
ontaining the heptad repeat of leucine/isoleucine resi-
ues. Figure 1B shows the sequence of the NDV F
rotein in this minimal HR2 domain with leucine/isoleu-
ine residues forming the heptad repeat shown in bold-
ace. We have focused on the carboxyl-terminal region of
he HR2 domain (from the third to fifth leucine residue),
ntroducing nonconservative mutations in residues that
otentially form contacts with the HR1 domain. The se-
uences of mutants characterized below are shown in
ig. 1B. Leucine residues, in the “a” position of the heptad
epeat, were changed to lysine singly or doubly. In addi-
ion, the third leucine (position 481) was also changed to
sparagine (L3N). Lysine residues in the “g” positions
ates the approximate location of important sequence elements related
he NDV F protein, from amino acid 462 to 499, is shown. The five “a”
ove the sequence. Also shown are the sequences of the HR2 domain
mino acid in the F sequence as well as an abbreviation in parentheses.e indic
ain of tere changed individually to alanine to generate K1A,
2A, and K3A mutant proteins. A double mutant (SK)
t
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t
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345HEPTAD REPEAT OF NEWCASTLE DISEASE VIRUS FUSION PROTEINsubstituted the serine at 486 with arginine and the lysine
at 487 with alanine.
Expression of mutant proteins
The mutant proteins were expressed in Cos-7 cells
using a simian virus 40-based vector and radioactively
labeled with [35S]methionine for 2 h at 48 h posttransfec-
ion as previously described (Sergel et al., 1993a,b; Ser-
el-Germano et al., 1994). The labeled proteins, precipi-
ated with anti-Ftail polyclonal antibody (Wang et al.,
992), were electrophoresed in the presence (Fig. 2A) of
educing agent. Under these conditions, the F0 and F1
proteins were resolved while F2 protein is not detected
(Sergel-Germano et al., 1994). All the L to K (“a” position
residues) mutant proteins were expressed at levels com-
parable to wild-type F protein and all mutant proteins
were proteolytically cleaved as efficiently as the wild-
type protein. Similar results were obtained with the K to
A (“g” position residues) mutant proteins (not shown).
Interestingly, all proteins that contained an alteration in
the leucine at amino acid 481 (L3) migrated slightly
slower than wild-type protein as did protein with a mu-
tation at the adjacent lysine residue at amino acid 480
(K1A) (Fig. 2C). This phenomenon was also noted for
proteins with a leucine to alanine change at the same
position (Reitter et al., 1995). The reason for this differ-
ence from wild-type protein is unknown.
The steady-state levels of mutant proteins were as-
sessed by Western analysis (Figs. 2B and 2C). As previ-
ously noted, detection of NDV F protein by Western
analysis is successful only if proteins are not boiled prior
to electrophoresis (Sergel-Germano et al., 1994). All mu-
tant proteins, including those with mutations in the “a”
position (Fig. 2B) as well as those with mutations in the
“g” position (Fig. 2C), were detected at levels comparable
to wild type. Thus none of the mutations significantly
increased the susceptibility of the protein to proteolytic
degradation. However, proteins with mutations at leucine
481 (L3) migrated as an oligomeric polypeptide with little
detectable material in the monomer region of the gel.
Sodium dodecyl sulfate (SDS)-resistant oligomeric struc-
tures formed by paramyxovirus F proteins have been
reported previously (Collins and Mottet, 1991; Sergel-
Germano et al., 1994) and can be seen in the lane
containing wild-type protein (Fig. 2B). However, the mu-
tation in L3 resulted in a protein that was exclusively in
this complex, a finding that suggests that these mutant
proteins are in a conformation somewhat different than
wild-type protein.
Surface expression
Proteolytic cleavage of all mutant proteins suggested
that these proteins were transported to the trans-Golgi
membranes (Doms et al., 1993) and, therefore, likely to
the cell surface. This conclusion was confirmed by flowcytometry. Cells were transfected with suboptimal levels
of DNA in order to avoid effects due to overexpression of
viral proteins, and the amounts of DNA used were care-
fully controlled in order to compare accurately expres-
sion levels. Comparisons of mutants with changes at “a”
positions with wild type showed that the number of
positive cells detected for each mutant transfection was
1.2 to 1.5 times greater than wild type (Fig. 3). The num-
bers of positive cells expressing mutants with K to A
FIG. 2. Expression of mutant proteins. (A) Precipitation of radiola-
beled F proteins synthesized in cells transfected with plasmids encod-
ing the mutant F proteins indicated above each lane. Cells transfected
with 0.5 mg of DNA/35-mm plate of Cos-7 cells were labeled with
[35S]methionine for 2 h at 48 h posttransfection and subjected to a 4-h
hase. Proteins present in extract from 2 3 105 cells were precipitated
with anti-Ftail antibody and the precipitated proteins were resolved on
polyacrylamide gels in the presence of reducing agent. Results with
L3N protein (not shown) were identical to the results with L3K protein.
(B and C) Results of Western analysis of mutant proteins (indicated
above each lane) under reducing conditions present in 5 3 105 cells at
48 h posttransfection. Results with L35K protein (not shown) were
identical to results with L34K protein. Anti-Ftail was used to detect F
protein. Positions of F0, uncleaved F protein, and F1, cleaved F protein,
ere determined by marker infected cell extracts electrophoresed in
arallel; V, vector.changes and the SK mutant were virtually identical to
wild type. Interestingly, Fig. 3 also shows that the inten-
e exper
lexa-48
346 MCGINNES ET AL.sities of fluorescence signal on cells transfected with the
L to K mutants were significantly greater than that de-
tected for wild type. The largest increases were detected
with cells expressing mutations in the L3 position or in
cells expressing the double mutant, L45K. Increases in
intensity of signal were not detected for K to A mutants or
the double mutant SK with the exception of K2A, which
yielded a slight increase in intensity of signal (Fig. 3). The
reasons for increased intensity of signal are unknown.
Fusion activity of mutant proteins
To measure the ability of these mutant proteins to
direct membrane fusion, Cos-7 cells were transfected
with only plasmids encoding mutant fusion proteins or
with plasmids encoding mutant fusion proteins as well
as a plasmid encoding the wild-type HN protein. The
FIG. 3. Analysis of surface expression of mutant proteins by flow cy
analysis by flow cytometry as described under Materials and Methods.
(cells transfected with vector alone and incubated with both primary a
cells expressing a mutant F protein. The figure shows the results of on
different preparations of mutant DNA. FL1-H, fluorescence gated for Afusion activities of these mutant proteins were quanti-
tated by syncytia size and frequency (Table 1), as previ-ously described (Sergel-Germano et al., 1994). None of
the F mutants were capable of significant syncytia for-
mation in the absence of HN protein expression (not
shown). In the presence of HN protein expression, the K
to A mutants and the SK mutant directed nearly wild-type
levels of syncytia formation. However, the syncytia sizes
directed by the L3K, L3N, and L5K mutant proteins were
very small and, importantly, the frequencies of these
small syncytia were quite low (Table 1). The syncytia size
and frequency directed by the L4K mutant protein activity
were reduced to some extent. The syncytia-forming ac-
tivities of the double mutant L35K and L45K proteins
were also minimal, while the L34K mutant protein di-
rected the formation of small syncytia but at reduced
efficiency. The properties of the L34K mutant were sur-
prising since a protein in which the L3 and L4 positions
. Cells transfected with 0.5 mg DNA/35-mm plate were processed for
imary antibody was anti-NDV antibody. Each panel shows background
ndary antibodies) and cells expressing wild-type F protein as well as
iment. Identical results were obtained in a duplicate experiment using
8-labeled antibody.tometry
The pr
nd secoare both substituted with alanine did not direct syncytia
formation (Reitter et al., 1995).
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347HEPTAD REPEAT OF NEWCASTLE DISEASE VIRUS FUSION PROTEINFusion activities of mutant proteins were also assayed
by measuring content mixing of fusing cells as described
under Materials and Methods. Content mixing was mea-
sured by b-galactosidase activity that could be ex-
pressed only upon cell fusion. Cells transfected with a
plasmid encoding the b-galactosidase gene under the
ontrol of a tet-sensitive transactivator were mixed with
ells transfected with HN and F cDNAs as well as a
lasmid encoding the tet-responsive transactivator of
ranscription. b-Galactosidase synthesis was induced
only when cells from the different populations fused. This
assay is specific for fusion directed by the HN and F
proteins as little enzyme activity was present when only
F cDNA was present or when only HN cDNA was
present (Table 1). Furthermore, there was little activity
after transfection with HN and an F cDNA that encoded
an uncleaved F protein (McGinnes et al., 2001). This
assay is also dependent upon the levels of expression of
F proteins (McGinnes et al., 2001).
Content mixing activities of the double mutants were
significantly reduced from wild type. Similarly, single mu-
TABLE 1
Fusion Activity of Mutant Proteins
DNA
Syncytia size
(percent of
wild type)
Syncytia frequency
(percent of
wild type)
Content mixing
(percent of
wild type)
.
N1Fwt 100 100 100
wt 5 (69) 3 1.8 (61)
N 5 (64) 2 5 (62)
.
N DNA 1:
wt 100 100 100
3K 30 (61.4) 20 12.5 (68)
3N 33 (620) 20 7 (60.5)
4K 47 (67) 115 90 (640)
5K 20 (65) 12 33 (62)
34K 43 (615) 40 14 (61)
35K 18 (611) 6 3.8 (63)
45K 18 (613) 10 6.5 (62)
1A 77 (65) 100 125 (65)
2A 88 (610) 100 235 (63)
3A 73 (610) 100 127 (64)
K 100 (610) 100 115 (64)
Note. A. Syncytia size, syncytia frequency, and content mixing activ-
ties directed by F wild-type protein or HN protein expressed alone are
hown as a percentage of values obtained with wild-type F protein
xpressed with HN protein. B. Syncytia size, syncytia frequency, and
ontent mixing activities directed by each mutant F protein cotrans-
ected with wild-type HN protein are expressed as a percentage of
alues obtained with wild-type F protein coexpressed with HN protein.
yncytia size and frequency were determined as described under
aterials and Methods. Content mixing was measured as b-galacto-
sidase activity as described under Materials and Methods.tations at the L3 site or the L5 site also inhibited content
mixing while the L4K mutation had little effect on thisactivity (Table 1). However, the content mixing activities
of the K to A mutant proteins were very similar to that of
the wild-type protein as would be expected from syncy-
tia-forming activities of these proteins.
To determine whether mutants that had little or no
ability to direct content mixing were capable of mediating
lipid mixing or hemifusion, red blood cells (RBC), labeled
with the fluorescent probe R18, were incubated with cells
expressing these mutant proteins as previously de-
scribed (Kemble et al., 1993, 1994). Figure 4 shows rep-
resentative results. As expected, cells expressing the HN
protein bound red blood cells but there was no transfer
of fluorescence from the RBC to the cells. In contrast,
cells expressing both HN and F proteins became fluo-
rescent as a result of the dye transfer. Cells expressing
L3K and L3N were defective in hemifusion, as was the
double mutant L35K. The L5K mutant protein as well as
the L45K mutant protein showed significant hemifusion
activity.
DISCUSSION
Several laboratories have reported properties of
paramyxovirus F proteins with conservative mutations of
hydrophobic residues in the “a” positions of the HR2
domain. It was shown that at least two of these residues
had to be changed to significantly affect fusion activity
(Buckland et al., 1992; Reitter et al., 1995) although the
tage of fusion affected by these mutations was not
eported. No change inhibited proteolytic cleavage or
urface expression (Reitter et al., 1995). To extend these
tudies, we characterized the properties of nonconser-
ative changes in residues on the hydrophobic face of
he helix as well as residues in the adjacent “g” posi-
ions.
ffects of mutations on intracellular processing and
urface expression of the F protein
The role of the HR2 domain in the formation of the
refusion paramyxovirus F protein is unknown even in
he light of the recently published structure of the NDV F
rotein (Chen et al., 2001). In this structure, the HR2
domain was missing and, therefore, its disposition in the
structure was unclear. Our analysis of mutants with sin-
gle or double nonconservative changes in leucine resi-
dues in the “a” position of the HR2 helix showed that no
change inhibited proteolytic cleavage or surface expres-
sion. In addition to the heptad repeat of leucine/isoleu-
cine residues, the NDV F protein in all strains of virus has
a striking heptad repeat of lysine residues that fall in the
“g” position of the helical structure of the HR2 domain.
Mutation of these residues also did not inhibit proteolytic
cleavage and levels of surface expression. We have
previously described properties of mutants with noncon-
servative changes that fall on the more charged side of
the helix (in the “b” and “c” positions of the helix) and
t
w
348 MCGINNES ET AL.FIG. 4. Lipid mixing directed by mutant proteins. Avian red blood cells, labeled with R18 as described under Materials and Methods, were added
o cells transfected with wild-type HN protein cDNA and wild-type or mutant F protein cDNA. After incubation at 37°C for 1 h, monolayers of cells
ere washed to remove unbound RBC and photographed through a Nikon fluorescence microscope.
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349HEPTAD REPEAT OF NEWCASTLE DISEASE VIRUS FUSION PROTEINfound that none of these significantly inhibit cleavage or
surface expression (Reitter et al., 1995). The NDV F pro-
ein HR2 domain also has a used glycosylation addition
ignal in position “e” of the helix (McGinnes et al., 2001).
Elimination of this carbohydrate by mutation of the addi-
tion signal had only a small effect on the surface expres-
sion of the protein (McGinnes et al., 2001). Thus no
mutation in the NDV F protein HR2 domain, conservative
or nonconservative, significantly inhibited surface ex-
pression, suggesting that the conformation of this do-
main may not be important for the formation of a trans-
port competent, prefusion form of the protein.
Effects of mutations on fusion activity of the F protein
Fusion mediated by viral glycoproteins is thought to
proceed through several steps initiated by the close
approach of attack and target membranes followed by
hemifusion or the fusion of the outer leaflets of the two
membranes, pore formation, and pore expansion and
syncytia formation (Hernandez et al., 1996). The com-
lexes formed between peptides from the HR1 and HR2
omains have been interpreted to mimic a structure in
he intact protein that mediates the close approach of the
arget and attack membranes. It has been proposed that
ormation of this complex, upon activation of the F pro-
ein, serves to initiate fusion (Baker et al., 1999; Mat-
hews et al., 1994; Skehel and Wiley, 1999, 2000; Weis-
enhorn et al., 1999). Thus inhibition of this complex
hould inhibit fusion at the earliest stage, that of close
pproach.
The structures of the complexes formed by peptides
rom the HR1 and HR2 domains of the simian virus 5 and
espiratory syncytial virus F proteins suggest that the “a”
osition residues contact the HR1 core trimer (Baker et
l., 1999; Zhao et al., 2000). Residues in the “e” and “g”
osition also potentially influence the interaction. Thus
ouble and perhaps single nonconservative changes in
hese residues should interfere with the interaction of the
R1 and HR2 domains and, therefore, block hemifusion
s well as content mixing and syncytia formation.
Mutations in the HR2 domain potentially also affect
nteractions with the HN protein. As with most paramyxo-
irus F proteins, fusion activity requires the coexpression
f HN protein (Lamb, 1993). Abundant evidence suggests
n interaction between the two proteins that is required
or fusion (Hu et al., 1992). While indirect evidence impli-
ates minimally the stalk domain of the HN protein in
hese interactions (Deng et al., 1995; Tanabayashi and
ompans, 1996; Tsurudome et al., 1995), the domains of
protein involved in these interactions are not clear. If,
owever, the HR2 domain interacts with the HN protein,
hen HR2 domain mutations may also affect fusion by
nterfering with interactions with the HN protein. Be-
ause the role of HN protein in the fusion activity of F
rotein is unclear, it is difficult to predict the step of
C
Musion that might be inhibited if there is a defect in HN–F
rotein interactions.
Nonconservative mutants with changes in the “g” po-
ition of the helix had no apparent effect on the fusion
ctivity of the protein, suggesting that these residues are
inimally involved in HR1 interactions in the NDV F
rotein or with HN protein. However, changes in “a”
osition residues did impact fusion activity of the protein.
n contrast to previously reported results obtained with
onservative mutations (Buckland et al., 1992; Reitter et
l., 1995), single nonconservative changes in “a” position
esidues interfered with fusion activity. However, the po-
ition of the residue is important to the degree and type
f effect. Alteration of the third leucine, which is in the
iddle of the HR2 domain, had the most effect on fusion.
emifusion was significantly inhibited as were subse-
uent stages in fusion, a result consistent with inhibition
f the close approach of membranes due to a defective
R1–HR2 interaction. Alteration of the L4 residue had
inimal effect on the activity of the protein, suggesting
hat this residue has only a small effect on HR1–HR2
omplex formation or HN protein interactions. Alteration
f the L5 residue or the L4 and L5 residues together also
nhibited syncytia formation and content mixing but min-
mally affected hemifusion. This phenotype might be ac-
ounted for by inefficient or less stable HR1–HR2 com-
lex formation. Alternatively, the L4 and L5 residues may
e less important in HR1–HR2 complex formation, but
ay be more important in pore formation. That HR2
utations, L5K and L45K, allow hemifusion (therefore,
lose approach) but are blocked at subsequent steps
uggests that the HR2 domain is also important in these
ubsequent steps. These results suggest that the HR2
omain is not only involved in the close approach of two
embranes but also plays an additional role in fusion, a
ole in steps related to content mixing and syncytia
ormation.
MATERIALS AND METHODS
ells and vectors
Cos-7 cells, obtained from the American Type Culture
ollection, were maintained in Dulbecco’s modified Ea-
le’s medium (DMEM) (Gibco BRL/Life Technologies)
upplemented with nonessential amino acids, vitamins,
enicillin/streptomycin, and 10% fetal calf serum. NDV
strain AV) HN and F protein genes were expressed in
os-7 cells using pSVL (Amersham Pharmacia Biotech)
s previously described (Sergel-Germano et al., 1994).
ite-specific mutagenesis
The F gene mutants were generated with the Sculptor
utagenesis kit from Amersham Pharmacia Biotech
orp. using protocols specified by the manufacturer.
utant oligonucleotides had appropriate codon changes
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350 MCGINNES ET AL.and were 25 to 30 bases in length. The entire gene of
each mutant F protein DNA was sequenced to verify that
no additional mutations were introduced into the se-
quence by the mutagenesis protocols. The mutations
isolated are shown in Fig. 1. Mutants are named, in
single-letter code, with the amino acid in wild type, the
position of the change, and the amino acid in the mutant.
Transfections
Transfections using lipofectamine (Gibco BRL/Life
Technologies) were done essentially as recommended
by the manufacturer. Cos-7 cells were plated at 3 3 105
per 35-mm plate. Twenty to 24 h later, the cells were
transfected. For each 35-mm plate, a mix of DNA (0.1–1
mg depending upon the experiment) in 0.1 ml OptiMem
(Gibco BRL/Life Technologies) and 10 ml of lipofectamine
in 0.2 ml of OptiMem was incubated at room temperature
for 40 min, diluted with 0.7 ml OptiMem, and added to a
plate previously washed twice with 2 ml of OptiMem.
Cells were incubated for 5 h, DNA–lipofectamine com-
plexes were removed, and then 2 ml of supplemented
DMEM was added.
Antibodies
Antibodies used were anti-Ftail and anti-NDV. Anti-
Ftail antibody was raised against a synthetic peptide
with the sequence of the cytoplasmic tail of the fusion
protein as described by Wang et al. (1992) and prepared
by the Peptide Core Facility of the University of Massa-
chusetts Medical School. Anti-NDV is a polyclonal anti-
serum raised in rabbits against UV inactivated virions as
previously described (Sergel et al., 1993b).
Radiolabeling and immunoprecipitation of protein
Transfected cells were radiolabeled for 2 to 4 h at
37°C in DMEM lacking methionine but containing 100
mCi of [35S]methionine (Amersham Pharmacia Biotech)
per milliliter. At the end of the labeling period, cells were
washed in phosphate-buffered saline (PBS) and lysed in
RSB buffer (0.01 M Tris–HCl, pH 7.4, 0.01 M NaCl) con-
taining 1% Triton X-100 and 0.5% sodium deoxycholate, 2
mg/ml iodoacetamide, and 0.2 mg/ml DNase as previ-
ously described (Sergel et al., 2000). Immunoprecipita-
tion of NDV proteins was accomplished as previously
described (Sergel et al., 1993b).
Western analysis of mutant proteins
Freshly prepared, unfrozen cell extracts prepared as
described for immunoprecipitation were diluted in sam-
ple buffer and loaded onto 10% polyacrylamide gels
without boiling. After electrophoresis, the gels were sub-
sequently equilibrated in transfer buffer (25 mM Tris, 192
mM glycine, 5% methanol, pH 8.2) and transferred to
Immobilon-P (Millipore Corp.) membranes. The mem-brane was blocked in PBS containing 0.5% Tween 20 and
10% nonfat dried milk for 2 h at room temperature or
overnight at 4°C. Membranes were washed in PBS con-
taining 0.5% Tween 20 and incubated with primary anti-
body diluted in PBS containing 0.5% Tween 20 and 0.5%
nonfat milk for 2 h at room temperature. Membranes
were washed and then incubated in secondary antibody,
anti-rabbit IgG coupled to horseradish peroxidase
(Boehringer Mannheim) diluted in PBS containing 0.5%
Tween 20 and 0.5% nonfat milk, for 1 h at room temper-
ature. Membranes were washed extensively and bound
antibody was detected using the ECL Western blotting
detection reagent system (Amersham Pharmacia Bio-
tech).
Flow cytometry
Cells transfected with 0.5 mg plasmid DNA/35-mm
late were removed from plates with Cell Dissociation
uffer (Sigma Co.) after a 1-min pulse in trypsin (50
mg/ml), washed in PBS containing 1% bovine serum
albumin and 0.02% azide (FACS buffer), and incubated
with anti-NDV antibody in FACS buffer for 1 h at 4°C.
After cells were washed three times with FACS buffer,
cells were incubated for 1 h at 4°C in FACS buffer with
goat anti-rabbit IgG coupled to Alexa dye 488 (Molecular
Probes). After three washes in FACS buffer, cells were
resuspended in PBS containing 2% paraformaldehyde
and subjected to flow cytometry (University of Massa-
chusetts Medical School Flow Cytometry Facility). All
experiments included cells transfected with vector alone
and incubated with both primary and secondary antibod-
ies.
Fusion assays
Syncytia formation. Cos-7 cells were cotransfected
with wild-type or mutant fusion protein genes and the
wild-type HN protein gene. At 48 h posttransfection, the
number of nuclei in 40 syncytia were counted to deter-
mine the average size of syncytia at each time point as
previously described (Sergel et al., 1993b). Values ob-
ained after transfection of the vector alone were sub-
racted. The frequency of syncytia formation was deter-
ined by averaging the number of syncytia containing
ive or more nuclei in 20 fields.
Content mixing. To measure content mixing, a plasmid
ncoding a tet-responsive transcriptional activator, pTet-
ff (Clontech), was transfected alone with HN and F
DNAs. A separate population of cells was transfected
ith pTRE2 (Clontech) with a b-galactosidase gene in-
erted into the cloning cassette. This plasmid contains a
et-responsive element upstream from a CMV promoter.
fter 20 h cells were trypsinized and Cos-7 cells trans-
ected with the b-galactosidase gene were mixed with
cells transfected with HN and F DNAs as well as the
plasmid pTet-Off and plated at subconfluent concentra-
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v
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351HEPTAD REPEAT OF NEWCASTLE DISEASE VIRUS FUSION PROTEINtions. Syncytia began to form at 40–42 h posttransfection
as cells became confluent. At 50 h posttransfection,
when extensive syncytia formation was evident, the
monolayers were lysed (Reporter Lysis Buffer, Promega),
and extracts were assayed for b-galactosidase activity.
ell extract diluted with Reporter Lysis Buffer was incu-
ated with equivalent volumes of 23 assay buffer (0.2 M
odium phosphate, pH 7.3, 1.3 mg/ml o-nitrophenyl b-D-
galactopyranoside, 2 mM MgCl2, 100 mM b mercapto-
ethanol) at 37°C for 45 min and adsorbance at 420 nm
was measured. Activity due to background fusion typical
of Cos-7 cells as well as background b-galactosidase
xpression was measured after cells were transfected
ith comparable amounts of vector alone and values
btained were subtracted from values obtained with
ells expressing HN and wild-type F or mutant F pro-
eins. Values obtained from cell extracts expressing HN
nd wild-type F protein were 5 to 6 times the background
alues.
Lipid mixing. The protocol used was similar to that
reviously described (Kemble et al., 1993, 1994). Avian
BC (Crane Laboratories) were washed in PBS, resus-
ended in PBS, and incubated with 15 mg/ml R18 (Mo-
lecular Probes) for 30 min at room temperature in the
dark. Three volumes of complete medium (DMEM with
10% fetal calf serum) was added and incubation was
continued for 30 min. The RBC were washed 4 times in
ice-cold PBS, resuspended in PBS containing CaCl2
(0.01%), and added to transfected cells that had been
washed in PBS with CaCl2. Cells were incubated for 1 h
at 37°C, washed in cold PBS containing CaCl2, and
isualized using a Nikon fluorescence microscope.
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